Align Technology (ALGN) to Release Quarterly Earnings on Wednesday

Align Technology (NASDAQ:ALGN - Get Free Report) is expected to be announcing its Q1 2025 earnings results after the market closes on Wednesday, April 30th. Analysts expect the company to announce earnings of $2.00 per share and revenue of $977.90 million for the quarter. Align Technology has set its Q1 2025 guidance at EPS.

Align Technology (NASDAQ:ALGN - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $1.96 EPS for the quarter, missing analysts' consensus estimates of $2.43 by ($0.47). Align Technology had a return on equity of 13.84% and a net margin of 10.54%. On average, analysts expect Align Technology to post $8 EPS for the current fiscal year and $9 EPS for the next fiscal year.

Align Technology Trading Down 1.2 %

Shares of ALGN traded down $2.26 during mid-day trading on Monday, reaching $181.09. The company's stock had a trading volume of 1,037,943 shares, compared to its average volume of 884,316. The stock has a market cap of $13.26 billion, a PE ratio of 32.28, a P/E/G ratio of 2.24 and a beta of 1.73. Align Technology has a 52 week low of $141.74 and a 52 week high of $313.29. The company's fifty day moving average price is $169.59 and its two-hundred day moving average price is $202.06.

Analysts Set New Price Targets

ALGN has been the subject of a number of recent research reports. Leerink Partners upgraded shares of Align Technology from a "market perform" rating to an "outperform" rating and boosted their price objective for the stock from $235.00 to $280.00 in a report on Monday, January 6th. Wells Fargo & Company initiated coverage on shares of Align Technology in a research report on Friday, February 14th. They issued an "overweight" rating and a $255.00 target price for the company. Piper Sandler reiterated an "overweight" rating and set a $235.00 target price (down from $270.00) on shares of Align Technology in a report on Tuesday, March 18th. UBS Group lowered their target price on shares of Align Technology from $240.00 to $215.00 and set a "neutral" rating for the company in a report on Thursday. Finally, Evercore ISI boosted their price objective on shares of Align Technology from $240.00 to $260.00 and gave the stock an "outperform" rating in a report on Thursday, February 6th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Align Technology currently has a consensus rating of "Moderate Buy" and a consensus target price of $246.17.

About Align Technology

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.